THE QUEENS MEDICAL CENTER — History
CCN 120001 | 3-year financial timeline | COVID resilience: 77/100
🛡️ Public data only — no PHI permitted on this instance.
$1.4B
Latest Revenue (FY2022)
+8.1%
Revenue CAGR (3yr)
1.0%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $1.2B | $1.4B | $1.4B | +3.0% | +8.1% |
| Operating Expenses | $1.3B | $1.5B | $1.4B | -7.6% | +2.6% |
| Operating Margin | -9.8% | -10.4% | 1.0% | +109.3% | +0.0% |
| Net Income | $-120M | $-144M | $14M | +109.6% | +0.0% |
| Licensed Beds | 674 | 674 | 674 | +0.0% | +0.0% |
| Total Patient Days | 183,505 | 199,151 | 219,023 | +10.0% | +9.2% |
| Medicare Day % | 21% | 19% | 18% | -3.5% | -7.2% |
| Medicaid Day % | 1% | 1% | 1% | -5.2% | -21.5% |
COVID Impact & Recovery
Resilience Score: 77/100 — Resilient — strong COVID recovery
Revenue recovery from FY2020 to FY2022: +16.8% ($1.2B → $1.4B)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▲ Growing
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+8.1%
This Hospital
+7.6%
State Avg
Latest Margin
1.0%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $1.5B | 6.4% |
| FY2024 (proj) | $1.6B | 11.8% |
| FY2025 (proj) | $1.7B | 17.2% |